baber/WOPTO huggingface dataset:
Patent CA-3115950-A1 (CA)
Title: Portable frozen confection machine
Inventor: RUPP CARL A
IPC: A23G9/12
Filed: 2017-11-01
Abstract: ABSTRACT  The disclosure extends to apparatuses, methods, and systems, for producing frozen confections and conditioning ice for use in frozen confections. A frozen confection machine includes a hopper portion for receiving ice into an interior, and a motor configured to rotate a drive shaft, a blade to condition the ice in the hopper during rotation of the motor. The frozen confection machine also includes a lid for selectively covering the interior of the hopper, a bias member for biasing the lid away from a closed position, and a switch for causing the motor to actuate in response to the lid being pressed to a closed position.   Date Recue/Date Received 2021-04-21
Patent CA-3116240-A1 (CA)
Inventor: JETTE ROGER
IPC: H02G3/08
Filed: 2021-04-23
Abstract: A cable support apparatus includes first and second horizontal supports spaced-apart and substantially parallel to one another, a plurality of vertical supports spaced-apart horizontally along the first and second horizontal supports, and at least one junction box assembly configured to hang from the first horizontal support. Each horizontal support is fomied from wire stock.  Each vertical support is fomied from wire stock and secured to each of the first and second horizontal supports. At least two of the vertical supports include cable-receiving segments that cooperate to define at least one cable-receiving channel extending horizontally. The at least one junction box assembly includes an input and an output for receiving cable ends of cables disposed within one of the at least one cable-receiving channels to enable joining of the cable ends within the junction box assembly.
Patent CA-3117426-A1 (CA)
Inventor: KELLER RALF
IPC: H04L29/08
Filed: 2018-12-03
Abstract: A method for discovering services in a telecommunication network provided by a network function, NF, in a Service Based Architecture, SBA, based telecommunication network, said method comprising the steps of receiving a discovery request, from a Network function, NF, consumer, for discovering an NF producer to interact with, wherein said discovery request comprises a Mobile Station International Subscriber Directory Number, MSISDN, associated with said NF consumer, transmitting to an address translate server, an address translate query, wherein said address translate query comprises said MSISDN, receiving an address translate response, wherein said address translate response comprises a Universal Resource Identifier, URI, and transmitting, to said NF, a discovery response, wherein said discovery response comprises an NF producer instance for interaction with said NF.
Patent CA-3118076-A1 (CA)
Title: User equipments, base stations, and methods
Inventor: NOGAMI TOSHIZO
IPC: H04W28/18
Filed: 2019-10-30
Abstract: A method for a user equipment (UE) which communicates with a base station is described. The method may comprise acquiring radio resource control (RRC) configuration information. The RRC configuration information may indicate one or more entries, each of the entries specifying a slot format. The method may also comprise receiving a physical signal and a physical downlink control channel (PDCCH) with a down link control (DCI) format. The DCI format may include a first information field and a second information field. The first information field may indicate an entry out of the entries. The second information field may indicates channel occupancy status of all channel access bandwidths in a bandwidth part.
Patent CA-3119654-A1 (CA)
Inventor: GLOCK GASTON
IPC: C25B9/17
Filed: 2020-01-21
Abstract: The invention relates to an electrolytic cell, more particularly for use in a motor vehicle, for electrolytically decomposing water into hydrogen (29) and oxygen (30), comprising an electrolyte tank (24) with electrolyte (28) and comprising a cathode (22) and an anode (23), which are each separately arranged in a cover (21). In order to be sufficiently robust yet space-saving, the electrolyte tank (24) is divided by a partition (32) into two partial electrolyte tanks (24'), the two covers (21) are each arranged in one of the partial electrolyte tanks (24'), at least the cover (21) with the cathode (22) leads into a gas syphon in the uppermost region of said cover, the outlet opening of which gas syphon is located in the electrolyte tank (24) completely below the liquid level of the electrolyte, and the electrolyte tank (24) has a separate gas outlet (26) for each of the gases (29, 30), which gas outlet is arranged at a vertical distance above the liquid level of the electrolyte (28).
Patent CA-3120667-A1 (CA)
Title: Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same
Inventor: HAN TAE DONG
IPC: A61K31/4439
Filed: 2019-12-12
Abstract: The present technology provides triazolopyridin-3-ones or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolopyridin-3-ones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
Patent CA-3121535-A1 (CA)
Inventor: HUNTER CHARLES ERIC
IPC: B05B5/00
Filed: 2013-04-19
Abstract: Un dispositif éjecteur (100) permettant d'éjecter des gouttelettes de fluide sur une surface comprend un mécanisme éjecteur (108) fixé à un réservoir de fluide (102) par l'intermédiaire d'une plaque de chargement de fluide (104) qui est conçu pour percer le réservoir et canaliser le fluide vers une surface arrière du mécanisme éjecteur (108) par action capillaire. Le mécanisme éjecteur (108) peut présenter une configuration symétrique par rapport au centre avec un actionneur piézo-électrique sans plomb et peut être couvert d'un couvercle à fermeture automatique.
Patent CA-3124648-A1 (CA)
Title: Methods of inhibiting neutrophil recruitment to the gingival crevice
Inventor: ZENOBIA CAMILLE
IPC: A61K8/27
Filed: 2019-12-17
Abstract: Methods of increasing proteins that reduce signals associated with neutrophil recruitment and reducing proteins that induce neutrophil recruitment within an individual's gingival crevice are disclosed. The methods comprise applying to the individual's oral cavity in an amount effective to increase proteins that reduce signals associated with neutrophil recruitment and reduce proteins that induce neutrophil recruitment within an individual's gingival crevice, an oral care composition comprising: zinc phosphate, stannous fluoride and optionally, an organic acid buffer system.
Patent CA-3124731-A1 (CA)
Title: Control mechanism for a chair
Inventor: COSTAGLIA MASSIMO
IPC: A47C9/00
Filed: 2020-02-13
Abstract: A control mechanism for a tiltable chair is easy to use and provides various options for positioning the chair. The control mechanism comprises a control handle, and four stop elements which limit a minimum distance between a base plate and a support plate at the position of the corresponding stop element. A stop element adjust mechanism is coupled to the control handle and adjusts the minimum distance of each stop element in response to actuating the control handle in the actuating direction. The control handle may be actuated in first, second and third handle positions. In the first handle position all four stop elements are in the retracted position, in the second handle position two stop elements are in the retracted position and the other two stop elements are in the extended position, and in the third handle position all four stop elements are in the extended position.
Patent CA-3126179-A1 (CA)
Title: Single-shot compressed optical-streaking ultra-high-speed photography method and system
Inventor: LIANG JINYANG
IPC: H04N5/3745
Filed: 2020-01-29
Abstract: A system and a method for single-shot compressed optical-streaking ultra-high-speed imaging, the system comprising a spatial encoding module spatially encoding the transient event with a binary pseudo-random pattern into spatially encoded frames; a galvanometer scanner temporally shearing the spatially encoded frames; and a CMOS camera receiving the temporally sheared spatially encoded frames, during one exposure time of the camera, for reconstructing the transient event. The method comprises spatial encoding a transient event; temporal shearing resulting spatially encoded frames of the event, spatio-temporal integration, and reconstruction.
Patent CA-3126232-A1 (CA)
Inventor: BINDSEIL GERON ANDRE
IPC: G01R33/385
Filed: 2021-07-29
Abstract: An asymmetric electromagnet system, method, and method of producing an asymmetric electromagnet system, wherein the asymmetric electromagnet system is for generating an imaging magnetic field in an imaging region with an imaging isocentre, the imaging region being asymmetrically positioned within a gradient coil bore inside a magnetic resonance imaging (MRI) system during imaging, the electromagnet assembly comprising: an asymmetric gradient coil configured to generate a gradient field in the asymmetrically positioned imaging region, at least one gradient axis having the gradient field with a constant offset component such that the position at which the gradient field passes through zero is offset with respect to the imaging isocentre of the asymmetrically positioned imaging region.
Patent CA-3127415-A1 (CA)
Title: Rigid needle shield remover for autoinjector
Inventor: PETIT LOUIS
IPC: A61M5/20
Filed: 2020-02-26
Abstract: Provided herein is a shield removal assembly for an auto injector including a cap remover configured to be grasped by a user, a retainer received within the cap remover and having at least one grasping feature configured to engage a proximal edge of an auto injector needle shield. The shield removal assembly is configured such that the needle shield of the auto injector can be advanced through the shield removal assembly from a first position in which the at least one grasping feature is located proximally of the proximal edge of the needle shield to a second position in which the at least one grasping feature abuts the proximal edge of the needle shield.
Patent CA-3128314-A1 (CA)
Title: Production of polyurethane foam
Inventor: WAGNER MICHAEL
IPC: C08L75/04
Filed: 2021-08-16
Abstract: Compositions for producing a rigid polyurethane foam are described, comprising at least one isocyanate component, a polyol component, optionally a catalyst which catalyzes the formation of a urethane or isocyanurate bond, wherein the composition has hydrocarbons having 3, 4 or 5 carbon atoms, hydrofluorocarbons, hydrofluoroolefins (HFO), hydrohaloolefins, oxygen-containing blowing agents and/or chlorohydrocarbons as blowing agent, and also comprises acrylate and/or methacrylate copolymers as foam stabilizers.
Patent CA-3129502-A1 (CA)
Title: New n-benzyl-2-phenoxybenzamide derivatives as prostaglandin e2 (pge2) receptors modulators
Inventor: PALOMINO LARIA JULIO CASTRO
IPC: C07D213/56
Filed: 2020-02-07
Abstract: The present invention relates to novel, optionally substituted, N-benzyl-2- phenoxybenzamide derivatives of formula (I), as modulators of EP4 and/or EP2 receptors of prostaglandin E2 (PGE2), to processes for their preparation, to pharmaceutical compositions comprising said compounds and to said compound for use in the treatment of pathological conditions, disorders or diseases that can improve by modulation of EP4 and/or EP2 receptors of prostaglandin E2 (PGE2) such as cancer disease, pain, inflammation, neurodegenerative diseases and kidney diseases.
Patent CA-3130765-A1 (CA)
Inventor: ZHOU HEYUE
IPC: A61P35/00
Filed: 2020-02-25
Abstract: The present disclosure provides BCMA binding proteins, particularly anti-BCMA antibodies, or antigen-binding portions thereof, that specifically bind BCMA and uses thereof. In one embodiment, the anti-BCMA antibody comprises an antigen binding portion that binds a human BCMA epitope and blocks binding (e.g, inhibits binding) of human APRIL and/or human BAFF to the human BCMA epitope. Various aspects of the anti-BCMA antibodies relate to antibody fragments, single-chain antibodies, pharmaceutical compositions, nucleic acids, recombinant expression vectors, host cells, and methods for preparing and using such anti-BCMA antibodies. Methods for using the anti-BCMA antibodies include in vitro and in vivo methods for binding BCMA, detecting BCMA and treating diseases associated with BCMA over-expression.
Patent CA-3138941-A1 (CA)
Title: Methods of identifying attributes of therapeutic proteins
Inventor: BONDARENKO PAVEL
IPC: G01N33/68
Filed: 2020-06-05
Abstract: Provided herein are methods of identifying structures, e.g., attributes, of a therapeutic protein or a target that affect an interaction between the therapeutic protein and the target. In exemplary embodiments, the method comprises: (a) applying a stress to a first sample comprising therapeutic proteins or targets; (b) contacting the first sample with a second sample comprising targets or therapeutic proteins to form a mixture comprising (i) therapeutic protein- target complexes, (ii) unbound therapeutic proteins, and (iii) unbound targets; and (c) separating the mixture into at least two fractions, wherein an unbound fraction comprises unbound therapeutic proteins or unbound targets and a bound fraction comprises therapeutic protein-target complexes; and (d) for each of the unbound fraction and bound fraction, identifying and quantifying the abundance of the structures, e.g., attribute, present on a species of the therapeutic protein or target.
Patent CA-3138945-A1 (CA)
Title: Methods for treating muscular dystrophy using inhibitory oligonucleotides to cd49d
Inventor: TACHAS GEORGE
IPC: A61K31/7115
Filed: 2020-05-06
Abstract: A method of modifying muscle or limb performance in a subject with or at risk of a condition associated with muscle atrophy, muscle fatty tissue, or pseudohypertrophy or a muscular dystrophy, by administering a pharmaceutical composition an inhibitory oligonucleotide to CD49d sufficient to modify one or more markers, signs or parameters of muscle fat, muscle performance or function, or limb performance or function. A method comprising the following steps: (i) determining the level of CD4+CD49d+ T cells in a blood sample from the subject; (ii) administering a course of antisense oligonucleotide and repeating step (i) at least once towards the end of the dosing period; (iii) within one week of dose completion repeat step (i); (iv) processing the results to determine whether the subject has or has not displayed a post-dose completion rebound, stability or loss in the level of CD4+CD49d+ T cells.
Patent CA-3140805-A1 (CA)
Inventor: REINE INESE
IPC: C07C317/22
Filed: 2020-05-20
Abstract: L'invention concerne un sel de formule III, un procédé de fabrication de celui-ci ainsi que des utilisations de celui-ci. Dans la formule III, X est H ou OH, Y est H ou un cation choisi dans le groupe constitué par Li, Na et K, le double trait pointillé-continu est une liaison simple ou une double liaison, et n est égal à 0,5 ou 1.
Patent CA-3140818-A1 (CA)
Inventor: ESENLIK SEMIH
IPC: H04N19/172
Filed: 2020-06-19
Abstract: L'invention concerne un procédé de codage mis en ?uvre par un dispositif de décodage, consistant à obtenir un flux binaire ; à obtenir une valeur d'un indicateur pour un bloc actuel selon le flux binaire ; à obtenir une valeur d'un premier paramètre correspondant au bloc actuel et une valeur d'un second paramètre correspondant au bloc actuel, en fonction de la valeur de l'indicateur et d'une table de recherche prédéfinie ; à obtenir une valeur d'une distance d'échantillon pour un échantillon qui est situé dans le bloc actuel, en fonction de la valeur du premier paramètre et de la valeur du second paramètre ; à obtenir une valeur de prédiction correspondant à l'échantillon, en fonction de la valeur de la distance d'échantillon correspondant à l'échantillon.
Patent CA-3141437-A1 (CA)
Inventor: REISKY LUKAS
IPC: C12P13/02
Filed: 2020-08-10
Abstract: La présente invention concerne un procédé au moyen duquel des polyuréthanes, qui ont été formés à partir de polyols de polyéther et d'isocyanates aromatiques, peuvent être décomposés en polyols de polyéther et en amines aromatiques.
Patent CA-3141552-A1 (CA)
Title: Articulated harness connection arrangement with integrated attachment element
Inventor: MONAHAN MICHAEL D
IPC: A62B35/00
Filed: 2020-06-26
Abstract: A connection arrangement for use with a wearable body harness includes a first connector having a first body component, a second body component, and an attachment element connected to each other by a rod having a longitudinal axis. The connection arrangement further includes a second connector removably connectable to the first connector. Each of the first body component, the second body component, and the attachment element are independently movable relative to each other about the longitudinal axis of the rod. The first connector and the second connector are removably connectable to each other via a locking and release mechanism between a first, locked configuration, where the first connector and the second connector are connected to each other, and a second, unlocked configuration, where the first connector and the second connector are disconnected from each other.
Patent CA-3142600-A1 (CA)
Title: Roof mounting apparatus and system for vehicle topper
Inventor: HORNSBY ERIC
IPC: G09F21/04
Filed: 2018-03-23
Abstract: A cross bar (124) for mounting a vehicle topper (110) to a roof (121) of a vehicle (120) has a center section (117) with a substantially rectangular cross section. Tapered sections (115) are attached at a proximal end to each side of the center section (117). Outer plates (113) are located on the distal end of each respective tapered section (115). The tapered sections (115) increase in cross sectional area from their distal end to their proximal end.
Patent CA-3145297-A1 (CA)
Inventor: FIELLO JONATHAN RICHARD
IPC: F02B37/00
Filed: 2020-07-24
Abstract: L'invention concerne un système d'admission commandé par turbo-amplification qui permet à un conducteur d'un véhicule de mieux maîtriser les performances de véhicule. Le système d'admission commandé par turbo-amplification comprend un module de commande qui est couplé à une admission d'air de chargeur d'air. Le module de commande ordonne à une unité de commande électronique du véhicule d'augmenter la pression de collecteur à un niveau supérieur avant de libérer la pression à travers une soupape de décharge de façon à fournir une plus grande puissance de sortie du moteur. Le système d'admission commandé par turbo-amplification comprend en outre un faisceau de câbles et un dispositif de réglage de signal. Le faisceau de câbles couple le module de commande à un capteur de pression d'entrée de turbo, à un capteur de pression absolue de collecteur, et à une unité de commande électronique du véhicule. Le dispositif de réglage de signal comprend un rhéostat qui permet un réglage manuel de la puissance de sortie du moteur.
Patent CA-3146777-A1 (CA)
Inventor: WANG ZHONGMIN
IPC: A61P35/00
Filed: 2020-07-31
Abstract: Disclosed is a monoclonal antibody. The monoclonal antibody has a heavy chain variable region comprising a CDR with an amino acid sequence of SEQ ID NOs: 19-21 and/or a light chain variable region comprising a CDR with an amino acid sequence of SEQ ID NOs: 22-24. Using the EU numbering system, the antibody has a heavy chain constant region mutated at any two or three of positions 234, 235, and 237. The affinity constant of the mutated antibody to Fc?RIIIa and/or C1q is lower than that before the mutation.
Patent CA-3151213-A1 (CA)
Title: Treating non-alcoholic steatohepatitis (nash) and hepatocellular carcinoma (hcc) with compounds binding the ectodomain of platelet glycoprotein ib (gpib) alpha
Inventor: HEIKENWALDER MATHIAS
IPC: A61K39/00
Filed: 2020-08-28
Abstract: The disclosure is based on the finding that a specific binding of compounds to the ectodomain of platelet glycoprotein lb (GPIb) alpha reduces the occurrence and progression of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), or of a disorder or condition associated with NAFLD or NASH, such as a disorder or condition developing from NAFLD or NASH (such as Hepatocellular Carcinoma). The present disclosure provides treatment options of NAFLD/NASH and HCC patients based on the specific binding to the GPIb ectodomain, and preferably by impairing GPIb-thrombin interaction. The disclosure provides medical treatments as well screening methods for the identification of compounds suitable for the treatment of NAFLD/NASH and HCC.
Patent CA-3153374-A1 (CA)
Inventor: SINGDAHLSEN EIVIND
IPC: C02F1/40
Filed: 2020-09-03
Abstract: A separation apparatus for separating hydrocarbons and water, comprising a vessel (1) and an insert (5, 6) within said vessel (1). The has a bottom (7), a conical wall (8) and a quiecer (10) at the top of the wall (8), which enclose a separation chamber (11). The insert (5, 6) has an inlet pipe (12) for a mixture of water and hydrocarbons and a spreader arrangement (13, 14) arranged inside the separation chamber (11), which directs an inflow of fluids in a tangential direction, setting the fluids into a tangential laminar swirl. The vessel (1) has at least one manhole (3, 4), and said insert bottom (7), wall (8) and quiecer (10) are assembled by a plurality of generally wedge shaped segments (7a-l, 8a-l, 10a-l) having a size that allows the segments (7a-l, 8a-l, 10a-l) to be brought through the manhole (3, 4).
Patent CA-3154135-A1 (CA)
Title: Systeme d'administration de medicament avec substrats empilables
Inventor: MCCULLOUGH TIMOTHY
IPC: A24F40/42
Filed: 2020-07-09
Abstract: La présente invention concerne un substrat électroconducteur (1002) revêtu d'une ou de plusieurs essences d'herbes, le substrat pouvant être une feuille plate de métal ou de polymère conducteur. Le revêtement (1120) peut être présent sous la forme de sections séparées sur le substrat et de multiples contacts conducteurs peuvent être présents sur le substrat ou peuvent être des composants séparés. De multiples substrats revêtus peuvent être empilés ensemble pour former une cartouche destinée à être utilisée dans un dispositif d'administration d'essences d'herbes.
Patent CA-3155378-A1 (CA)
Inventor: COCHRAN ROBERT
IPC: A01D90/00
Filed: 2021-11-04
Abstract: A bale processor and transport apparatus includes a bale processor, and a hitch assembly attached to a rear end of the bale processor. A bale trailer is attached to the hitch assembly, and the bale trailer comprises a trailer conveyor operative to move bales forward on the bale trailer. A lift conveyor is connected to the rear end of the bale processor above the hitch, and the lift conveyor is operative, when in an operating position, to receive a transported bale from the trailer conveyor and move the transported hale forward to a lift position, and further operative to pivot the transported hale upward and forward into a chamber of the bale processor.
Patent CA-3155857-A1 (CA)
Inventor: WANG HUI-LING
IPC: C07D471/04
Filed: 2020-10-22
Abstract: La présente invention concerne des inhibiteurs de KRAS G12C et de KRAS G12D, une composition de ceux-ci et des procédés d'utilisation de ceux-ci. Ces inhibiteurs sont utiles pour traiter un certain nombre de troubles, notamment le cancer du pancréas, le cancer colorectal et le cancer du poumon.